Compound ID | 343

Update compound information

RWJ 333442

Class: Beta-lactam

Agent Type: Semisynthetic; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Cell wall synthesis inhibitor
Combined with other compounds: Could be combined with aztreonam, fosfomycin, gentamicin or levofloxacin for empiric therapy
Institute where first reported: Microcide Pharmaceuticals; Essential Therapeutics, USA (Ceased)
Year first mentioned: 2000
Development status: Experimental
Reason dropped: Essential Therapeutics closed down in 2004
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/substance/273482665
Citations:
  • https://pubmed.ncbi.nlm.nih.gov/11816832/
  • https://journals.asm.org/doi/full/10.1128/aac.47.6.2043-2046.2003?origin=publication_detail%3D

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.